Symbol Surfing makes it fast & easy to find your next great idea. Just select a channel to get started.
AbbVie trades on the NYSE. ABBV's market cap is 202.0 Billion.
AbbVie is a drug company with a strong exposure to immunology and oncology. The company's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.